Tobira Therapeutics Lands $15,000,000 New Round

  • Feed Type
  • Date
    7/1/2014
  • Company Name
    Tobira Therapeutics
  • Mailing Address
    701 Gateway Blvd. South San Francisco, CA 94080 USA
  • Company Description
    Tobira Therapeutics acquires, develops, and commercializes innovative products for the treatment of important unmet medical needs in infectious diseases such as HIV/AIDS, hepatitis, and other associated infectious conditions.
  • Website
    http://www.tobiratherapeutics.com
  • Transaction Type
    Debt
  • Transaction Amount
    $15,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The facility will support the development of CVC for the treatment of nonalcoholic steatohepatitis (NASH) and for working capital and general corporate needs.
  • M&A Terms
  • Venture Investor